Pharmaceutical composition for treating cancer
OwnerBakulesh Mafatlal Khamar, Indravadan Ambalal Modiinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to increase in survival of mammals suffering from desmocollin 3 expressing cancers. Mycobacterium w is administered to mammals suffering from desmocollin-3 expressing cancers. The administration of Mycobacterium w results in control of tumor and improvement in survival. Mycobacterium w can also be used along with other therapeutic agent(s)/modalities as per the requirement. The squamous type of non small cell lung cancer is known to be desmocollin-3 expressing cancer. Other cancers also express desmocollin-3.
Claims7
Mycobacterium w for use in the treatment of a desmocollin-3 expressing cancer.
Dependencies are inferred from the claim text.